These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33791700)

  • 1. Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.
    Spratt AN; Kannan SR; Woods LT; Weisman GA; Quinn TP; Lorson CL; Sönnerborg A; Byrareddy SN; Singh K
    bioRxiv; 2021 Mar; ():. PubMed ID: 33791700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.
    Spratt AN; Kannan SR; Woods LT; Weisman GA; Quinn TP; Lorson CL; Sönnerborg A; Byrareddy SN; Singh K
    Comput Struct Biotechnol J; 2021; 19():3799-3809. PubMed ID: 34188776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging SARS-CoV-2 variants of concern.
    Sanyaolu A; Okorie C; Marinkovic A; Haider N; Abbasi AF; Jaferi U; Prakash S; Balendra V
    Ther Adv Infect Dis; 2021; 8():20499361211024372. PubMed ID: 34211709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
    Biswas SK; Mudi SR
    Genomics Inform; 2020 Dec; 18(4):e44. PubMed ID: 33412760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
    Tchesnokova V; Kulasekara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    J Clin Microbiol; 2021 Oct; 59(11):e0092121. PubMed ID: 34379531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity.
    Tang H; Gao L; Wu Z; Meng F; Zhao X; Shao Y; Shi X; Qiao S; An J; Du X; Qin FX
    Front Cell Infect Microbiol; 2021; 11():720357. PubMed ID: 34722330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.
    Flores-Alanis A; Cruz-Rangel A; Rodríguez-Gómez F; González J; Torres-Guerrero CA; Delgado G; Cravioto A; Morales-Espinosa R
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33572190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants.
    Tchesnokova V; Kulakesara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Concern and Interest SARS-CoV-2 Variants.
    Janik E; Niemcewicz M; Podogrocki M; Majsterek I; Bijak M
    Pathogens; 2021 May; 10(6):. PubMed ID: 34064143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.